About this trial
The purpose of the present study was to examine the effectiveness of acute A-GPC supplementation on upper and lower body muscular strength, endurance, power, and global levels of activation.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Recreationally-trained males, college-aged
Disqualifiers
If the subjects report: 1) cardiovascular disease, metabolic, renal, hepatic, or musculoskeletal disorders; 2) use of any medications; 3) use of nutritional supplements; 4) habitual use of caffeine (≥1 caffeinated beverage per day); 5) participation in another clinical trial or investigation of another nutritional product within 30 days of screening/enrollment.
Trial design
Crossover
Treatments tested in this trial
L-Alpha glycerylphosphorylcholine
Dietary supplementOral, 900 mg, single dose study
Microcrystalline Cellulose
Dietary supplementOral, 900 mg, single dose study
Treatment groups
Trial outcomes
Primary outcomes
Maximal Voluntary Isometric Contraction
MVIC of leg extensors at 120 degrees between thigh and leg
Muscle Activation
EMG amplitude during MVIC
Secondary outcomes
Wingate Anaerobic Test
Peak, mean, minimum power and fatigue index
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Northern Illinois University
Lead sponsor
Mayo Clinic
Collaborator
This trial is not recruiting at the moment. You can still explore other options: